GOLPH3 regulates the migration and invasion of glioma cells though RhoA

Biochemical and Biophysical Research Communications

Volumn 433, Issue 3, 2013, Pages 338-344

  Zhou, Xiuping ^a   Zhan, Wenjian ^a   Bian, Wenbin ^a   Hua, Lei ^a   Shi, Qiong ^a   Xie, Shao ^a   Yang, Dongxu ^a   Li, Yanwei ^a   Zhang, Xu ^a   Liu, Guanzheng ^a   Yu, Rutong ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Glioma; GOLPH3; Invasion; Migration; RhoA

Indexed keywords

BETA ACTIN; GELATINASE A; GOLGI PHOSPHOPROTEIN 3; MATRIX METALLOPROTEINASE 14; PHOSPHOPROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CYTOSKELETON; GENE OVEREXPRESSION; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETON; DIFFUSION CHAMBERS, CULTURE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; PLASMIDS; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84876334224     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.003     Document Type: Article

References (33)

1. Onyegbutulem H.C., PI H.O., Reimann M., et al. Metabolic syndrome in Africa: an emerging perspective. Horm. Metab. Res. 2009, 41:75-78.
2. Ohgaki H., Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J. Neuropathol. Exp. Neurol. 2005, 64:479-489.
3. Holland E.C. Gliomagenesis: genetic alterations and mouse models. Nat. Rev. Genet. 2001, 2:120-129.
4. Manji H.K., Quiroz J.A., Sporn J., et al. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol. Psychiatry 2003, 53:707-742.
5. Yokoi S., Yasui K., Saito-Ohara F., et al. A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Am. J. Pathol. 2002, 161:207-216.
6. Hung W.C., Tseng W.L., Shiea J., et al. Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells. Cancer Lett. 2010, 288:156-161.
7. Scott K.L., Kabbarah O., Liang M.C., et al. GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature 2009, 459:1085-1090.
8. Dippold H.C., Ng M.M., Farber-Katz S.E., et al. GOLPH3 bridges phosphatidylinositol-4-phosphate and actomyosin to stretch and shape the Golgi to promote budding. Cell 2009, 139:337-351.
9. Schmitz K.R., Liu J., Li S., et al. Golgi localization of glycosyltransferases requires a Vps74p oligomer. Dev. Cell 2008, 14:523-534.
10. Tu L., Tai W.C., Chen L., et al. Signal-mediated dynamic retention of glycosyltransferases in the Golgi. Science 2008, 321:404-407.
11. Zeng Z., Lin H., Zhao X., et al. Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor. Clin. Cancer Res. 2012, 18:4059-4069.
12. Hua X., Yu L., Pan W., et al. Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer. Diagn. Pathol. 2012, 7:127.
13. Li H., Guo L., Chen S.W., et al. GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer. J. Transl. Med. 2012, 10:168.
14. Zhou J., Xu T., Qin R., et al. Overexpression of Golgi phosphoprotein-3 (GOLPH3) in glioblastoma multiforme is associated with worse prognosis. J. Neurooncol. 2012, 110:195-203.
15. Iwanicki M.P., Vomastek T., Tilghman R.W., et al. FAK, PDZ-RhoGEF and ROCKII cooperate to regulate adhesion movement and trailing-edge retraction in fibroblasts. J. Cell Sci. 2008, 121:895-905.
16. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer. 2002, 2:161-174.
17. Vihinen P., Ala-aho R., Kahari V.M. Matrix metalloproteinases as therapeutic targets in cancer. Curr. Cancer Drug Targets 2005, 5:203-220.
18. Sato H., Takino T., Okada Y., et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994, 370:61-65.
19. Wan G., Too H.P. A specific isoform of glial cell line-derived neurotrophic factor family receptor alpha 1 regulates RhoA expression and glioma cell migration. J. Neurochem. 2010, 115:759-770.
20. Liu L., Luo Y., Chen L., et al. Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity. J. Biol. Chem. 2010, 285:38362-38373.
21. Li X.Y., Liu W., Chen S.F., et al. Expression of the Golgi phosphoprotein-3 gene in human gliomas: a pilot study. J. Neurooncol. 2011, 105:159-163.
22. Ridley A.J., Schwartz M.A., Burridge K., et al. Cell migration: integrating signals from front to back. Science 2003, 302:1704-1709.
23. Nakada M., Nakada S., Demuth T., et al. Molecular targets of glioma invasion. Cell. Mol. Life Sci. 2007, 64:458-478.
24. Yamazaki D., Kurisu S., Takenawa T. Regulation of cancer cell motility through actin reorganization. Cancer Sci. 2005, 96:379-386.
25. Yan B., Chour H.H., Peh B.K., et al. RhoA protein expression correlates positively with degree of malignancy in astrocytomas. Neurosci. Lett. 2006, 407:124-126.
26. Esparza J., Vilardell C., Calvo J., et al. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. Blood 1999, 94:2754-2766.
27. Matsui T., Amano M., Yamamoto T., et al. Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J. 1996, 15:2208-2216.
28. Watanabe N., Madaule P., Reid T., et al. P140mDia, a mammalian homolog of Drosophila diaphanous, is a target protein for Rho small GTPase and is a ligand for profilin. EMBO J. 1997, 16:3044-3056.
29. Narumiya S., Tanji M., Ishizaki T. Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev. 2009, 28:65-76.
30. Schram K., Ganguly R., No E.K., et al. Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskeletal reorganization and leads to enhanced cell migration. Endocrinology 2011, 152:2037-2047.
31. Heasman S.J., Ridley A.J. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat. Rev. Mol. Cell Biol. 2008, 9:690-701.
32. O'Connor K.L., Nguyen B.K., Mercurio A.M. RhoA function in lamellae formation and migration is regulated by the alpha6beta4 integrin and cAMP metabolism. J. Cell Biol. 2000, 148:253-258.
33. Genda T., Sakamoto M., Ichida T., et al. Cell motility mediated by rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma. Hepatology 1999, 30:1027-1036.